- Home
- NICM vs NRXS Comparison
NICM vs NRXS Comparison
Compare NICM & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NICM | NRXS |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | Canada | United States |
| Employees | 25 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 82.0M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NICM | NRXS |
|---|---|---|
| Price | $5.06 | $6.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 4.6K | ★ 161.6K |
| Earning Date | 11-27-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | $355.99 | $118.53 |
| Revenue Next Year | $161.43 | $101.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $4.71 | $2.21 |
| 52 Week High | $7.00 | $9.33 |
Technical Indicators
Market Signals| Indicator | NICM | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 38.06 |
| Support Level | $4.71 | $5.69 |
| Resistance Level | $5.68 | $7.79 |
| Average True Range (ATR) | 0.25 | 0.51 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 20.59 | 23.34 |
Price Performance
Historical ComparisonAbout NICM Nicola Mining Inc. American Depositary Shares
Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).